Enterprise League logo

Product

ASPIRET Platform

BIOTECHNOLOGY

ABOUT THE PRODUCT

A next-generation T cell therapy platform that redirects the TCR/CD3 complex to overcome key limitations of conventional CAR-T and TCR-T therapies, delivering robust, sustained, and safer immune responses against solid tumors.

Information is owner-confirmed

Last updated 5 days ago

Price range
N/A

Other products/services from TCRCure Biopharma Corp.